Data Loading...
105001 Insigneo showcase newsletter
42 Downloads
2.62 MB
Twitter Facebook LinkedIn Copy link
RECOMMEND FLIP-BOOKS
HBB showcase with process
dislikes that should inform the response, as well as any special heirloom pieces you would like inco
WA Art Showcase 25.05.21
WA Art Showcase 25.05.21 Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page
Testimonials for the Showcase SW
Testimonials for the Showcase SW Tes$monials from Delegates “I found the business showcase very info
Magic Media Showcase Sept 2021
Magic Media Showcase Sept 2021 Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8
Doveton Business Showcase Offer
Doveton Business Showcase Offer Proud to be a print partner of A4 - 8 Page Brochure (210x297mm) • Pr
ADA Capability Showcase
VirtualTour . ACCREDITED BY ETHICAL CLOTHING AUSTRALIA Did you know ADA was the first business accre
Floorplans for Business Showcase SW OCT16
EXIT S5 S1 S2 S3 S4 NETWORKING ZONE S10 S11 S12 S13 S14 S15 S8 S9 REGISTRATION ZONE S20 S21 S22 S23
newsletter
Hobbies: Estar con sus hijos Color Favorito: Azul Valor más importante para usted: La integridad Una
Showcase Events Limited - Privacy and Data Policy
Showcase Events Limited - Privacy and >Page 1 Page 2 Page 3 Page 4 Made with FlippingBook - professi
2020 NJ STEM Month Virtual Showcase
or organiza- tions moving beyond silos to create a connection in New Jersey. Sanofi, Students 2 Scie
2022
TRAINING
PROJECT NEWS
EVENTS ROUNDUP
1
CONTENTS AND WELCOME
Contents Inside this issue
technologies and we are pleased to further develop our strategic partnerships with industrial collaborators (see Jan Wolber GE feature on page five). At a local level our Commercialisation Manager, Alex Wilkinson, has been actively engaging with members to help define pathways to commercial translational impact. Building on the theme of multi-scale computational modelling, Insigneo is bringing together researchers working on cutting-edge biomedical imaging and smart sensing technologies for the understanding of living systems from the molecule through to the patient. Integrating these images and signals with modelling and simulation gives an augmented understanding of the basic biology and disease pathophysiology at the cell, organ, patient and population level. We are particularly pleased with the interest in Insigneo from colleagues working in the faculty of science at this interface of physical and biomedical science. With our new research theme structure, we have assembled a collection of dynamic researchers across the University of Sheffield, the University of Sheffield’s Advanced Manufacturing Research Centre (AMRC), the Sheffield Teaching Hospital and the Sheffield Children’s Hospital directing these interlocking themes in our new, expanded research director structure which features early career scientists and clinical pioneers of Insigneo technologies (see theme diagram page four).
2
Introduction
4
Insigneo research themes Partnerships and placements
5
6
Clinical translation
6
12
8
Insigneo timeline
10
Updates from our research themes
13
Events
Insigneo Organisational Structure
14
Training
Thanks to the efforts of all the members and the continued support of our stakeholders over these last ten years the future for Insigneo and in silico medicine is bright. Hope to see you at the 10th anniversary showcase.
15
Summer research
14
programme 13
Welcome
Jim Wild & Damien Lacroix
Insigneo Executive Director - Professor Jim Wild
Welcome from Jim Wild & Damien Lacroix who were formally appointed to their new roles in 2021.
(Department of Infection, Immunity and Cardiovascular Disease)
Having been members of Insigneo since its inception we have seen the institute grow and evolve to meet the cross-disciplinary research challenges that medical technology and basic science can help address in a modern healthcare setting. Ten years ago, the focus of the institute was very much driven by the excellent work of the founders establishing the field of research of the virtual physiological human (VPH) in collaboration with modellers, experimentalists and clinicians, and where patient- specific modelling was developed to understand disease processes and predict outcomes. In the last ten years, the institute has actively worked with the VPH Institute and the Avicenna Alliance to see the concept of in silico clinical trials being adopted by regulatory bodies as a means of faster introduction and more effective validation of devices and interventions;
we are proud to say that Insigneo has been at the forefront of this endeavour.
arrived in a healthcare setting with a significant push from industry. We are combining our patient-specific physics- based modelling approach with >Page 1 Page 2-3 Page 4-5 Page 6-7 Page 8-9 Page 10-11 Page 12-13 Page 14-15 Page 16
Made with FlippingBook Learn more on our blog